Learn More About Biolyse Pharma Corporation

Biolyse Pharma Corporation began in 1980, and worked researching various bioactive natural compounds found in the diverse biomes of Eastern Canada.

Our Story

At Biolyse, our name is our inspiration. Biolyse means “the separation of biological substances into their component parts”. Using the techniques of isolation and purification, we have been producing naturally based medical products and chemical extracts of high quality and concentration for over twenty years.

The recognize the importance of continued exploration to find valuable new natural compounds in place of more costly proprietary synthetic technologies. Biolyse extracts concentrates and purifies natural bioactive compounds.

The objectives of the pharmaceutical industry used to be simple: a dedication to science, and a desire to benefit humanity. In today’s market-driven economy, large pharmaceutical companies can sometimes lose sight of these objectives as scientific discovery takes a backseat to profitability. Biolyse however, maintains the ideals of simpler times. We pride ourselves on our ability to make our high-quality innovative products available to those who need them.

Biolyse endeavors to allow our hard-earned discoveries to benefit all people and markets by providing dedicated service and a personal approach.

Our History

Biolyse Pharma Corporation began in 1980, and worked researching various bioactive natural compounds found in the diverse biomes of Eastern Canada.

In 1999, Biolyse located its head office in St.Catharines, Ontario, in the Niagara peninsula. Our proximity to Toronto, Buffalo and Chicago allows us to better meet the demands of international markets.

Today, Canada and the world prepare for a potential onslaught from a deadly avian influenza virus. Exciting developments at Biolyse Pharma have placed us at the forefront of the Canadian pharmaceutical industry in the fight against a possible influenza pandemic. For two years, Biolyse engineers have been developing a generic low cost version of the anti-viral medication oseltamivir and have secured a plentiful and stable supply of the active component within Canada. With our proven record of quality and efficiency, Biolyse stands ready to begin production for developing nations upon receiving a voluntary license from the patent holders or a compulsory license from Ottawa .

Until recently, our main focus has been the development of Paclitaxel for Injection, a chemotherapeutic treatment used in the fight against various forms of cancer. By concentrating on this one cancer medication and thoroughly investigating every aspect of its development, Biolyse can manufacture Paclitaxel efficiently while maintaining a lower cost to our ultimate consumers — the cancer patients who so badly need it.

Biolyse Pharma remains open to collaborations and committed to developing high quality pharmaceuticals at an accessible cost. We believe that, by expanding our products and continually refining our unique methods of extraction and purification, we can provide solutions to a varied customer base. Potential applications for our services include pharmaceutical, biotechnology or fine chemical industries, as well as personal care product manufacturers and food production industries. Marketing products on a worldwide scale, Biolyse Pharma is poised to become a leader in the Canadian pharmaceutical industry.

Biolyse endeavors to provide quality products of the purest form, available to the consumer market at reasonable prices. We adhere to principles of hard work and continuous innovation at all levels of our company. We do not forget that our institution is based on the health of real people. We are dedicated to creating effective treatments and making them accessible to the patients who need them. At Biolyse, we are committed to reinvesting our profits back into paclitaxel research and development, in an effort to fight disease, and to help create a brighter tomorrow.

A Message From Our President

Biolyse endeavors to provide quality products of the purest form, available to the consumer market at reasonable prices. We adhere to principles of ethics, hard work, and continual innovation at all levels of our company. We do not forget that our institution is based on the health of real people, whose well-being is more than important to us. We have focused our efforts on Paclitaxel for Injection and we are dedicated to providing better access of this treatment to the patients in need. At Biolyse, we are committed to returning our profits back into continual research and development, in an effort to fight disease, and in the hope to help create a brighter tomorrow.

Brigitte Kiecken,
President
Biolyse Pharma Corporation.